SCHEMBL10102275

SCHEMBL10102275

Cc1cc2c(cc1O)/C(=N/OCc1ccc3nonc3c1)CC2

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36
MAPK1 P28482 1/20 0.36
HSD17B10 Q99714 1/20 0.36
RAB9A P51151 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.34
ENPP2 Q13822 1/20 0.34
KCNJ1 P48048 2/20 0.33
KCNH2 Q12809 2/20 0.33
NR3C1 P04150 1/20 0.33
PGR P06401 1/20 0.33
PKM P14618 1/20 0.31
MEN1 O00255 1/20 0.30
NPC1 O15118 1/20 0.30
MAPT P10636 1/20 0.30
NFKB1 P19838 1/20 0.30
NFKB2 Q00653 1/20 0.30
KMT2A Q03164 1/20 0.30
RELA Q04206 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10102274 0.94 L3MBTL1 (0.40) ALDH1A1ALOX15TSHRMAPK1HSD17B10
SCHEMBL10102273 0.91 ALDH1A1 (0.38) ALDH1A1ALOX15TSHRMAPK1HSD17B10
SCHEMBL661586 0.88 TUBB4A (0.39) ALDH1A1RAB9AL3MBTL1PKMMAPT
SCHEMBL661585 0.88 TUBB4A (0.39) ALDH1A1RAB9AL3MBTL1PKMMAPT
SCHEMBL10102267 0.85 L3MBTL1 (0.42) ALDH1A1ALOX15TSHRMAPK1HSD17B10
SCHEMBL661283 0.83 HCRTR1 (0.38) ALDH1A1ALOX15TSHRMAPK1HSD17B10
SCHEMBL661282 0.83 HCRTR1 (0.38) ALDH1A1ALOX15TSHRMAPK1HSD17B10
SCHEMBL10101788 0.82 MAOA (0.36) ALDH1A1ALOX15MAPK1HSD17B10RAB9A
SCHEMBL660478 0.82 RAB9A (0.41) ALDH1A1MAPK1RAB9AL3MBTL1PKM
SCHEMBL660479 0.82 RAB9A (0.41) ALDH1A1MAPK1RAB9AL3MBTL1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8536157-B2 Non-steroidal compounds THE UNIVERSITY OF MELBOURNE (AU) 2013-09-17 US disclosed
US-20120046255-A1 NON-STEROIDAL COMPOUNDS THE UNIVERSITY OF MELBOURNE of ROYAL PARADE PARKVILLE (AU) 2012-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046255-A1 NON-STEROIDAL COMPOUNDS PTGES2, PTGES, PTGES3 ALDH1A1 2237/4885ALOX15 36/4885TSHR 3564/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.